Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc.

ENTRY DENYING ZENITH’S MOTION FOR SUMMARY JUDGMENT AND DENYING IN PART AND GRANTING IN PART LILLY’S MOTION FOR SUMMARY JUDGMENT

BARKER, District Judge.

In 1995, Plaintiff Eli Lilly and Company (“Lilly”) filed this action against Defendant Zenith Goldline Pharmaceuticals, Inc. (“Zenith”), formerly Zenith Laboratories, Inc., and three other American and Italian drug companies 1 alleging infringement of certain patents owned by Lilly for the making of cefaclor, an antibiotic. Later in 1995, Zenith filed a counterclaim alleging antitrust violations under federal law and unfair competition claims…